Western Standard Partners L.P., Director at MERRIMACK PHARMACEUTICALS INC (MACK), bought 100,340 shares at $12.50 ($1.3M) on 2023-11-14, disclosed to the SEC on 2023-11-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 10,887 | $136K | 10.9% |
| 2 | $12.50 | 10,887 | $136K | 10.9% |
| 3 | $12.50 | 39,283 | $491K | 39.1% |
| 4 | $12.50 | 39,283 | $491K | 39.1% |
| Total | $12.50 avg | 100,340 | $1.3M | 100% |
| Filing → |
| MACK | BUY | 2021-04-16 | $584K | — | Filing → |
| MACK | BUY | 2021-04-15 | $124K | — | Filing → |
| MACK | BUY | 2020-04-07 | $46K | — | Filing → |